SEC Form 4 · accession 0001179110-18-007440
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Burton G Malkiel
Director
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 21, 2018 | P | 1,000 | $22.54 | A | 56,757 | D | |
| Ordinary Shares | holding | — | — | — | 15,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.